PRINSTON INC FDA Approval ANDA 078644

ANDA 078644

PRINSTON INC

FDA Drug Application

Application #078644

Documents

Letter2007-07-16

Application Sponsors

ANDA 078644PRINSTON INC

Marketing Status

Prescription001

Application Products

001TABLET;ORAL200MG0NEVIRAPINENEVIRAPINE

FDA Submissions

ORIG1AP2012-05-22
LABELING; LabelingSUPPL2AP2015-01-20STANDARD
LABELING; LabelingSUPPL3AP2020-06-29STANDARD
LABELING; LabelingSUPPL5AP2020-06-29STANDARD

Submissions Property Types

ORIG1Null7
SUPPL2Null15
SUPPL3Null7
SUPPL5Null7

TE Codes

001PrescriptionAB

CDER Filings

PRINSTON INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 78644
            [companyName] => PRINSTON INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"NEVIRAPINE","activeIngredients":"NEVIRAPINE","strength":"200MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"NEVIRAPINE","submission":"NEVIRAPINE","actionType":"200MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.